Additionally, as demonstrated in the case of HIF2α, it is also possible that while the high expression of NRF2 is associated with better survival in ccRCC, NRF2 can still be a target for tumor elimination. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.